Narrative review / 2018
The International Ketogenic Diet Study Group updated consensus recommendations for managing children on ketogenic dietary therapies for epilepsy.
Ketogenic dietary therapies (KDTs) serve as established nonpharmacologic treatments for intractable childhood epilepsy. The International Ketogenic Diet Study Group presented a revised consensus guideline incorporating recent research on dietary options, indications, side effects, supplementation, and discontinuation. Authors also completed an institutional practice survey comparing modern protocols with the original 2009 consensus to identify clinical trends over the past decade.
- Study type
- Expert consensus guideline and practice survey
- Who was studied
- Children receiving dietary therapies for epilepsy
- What was measured
- Clinical management recommendations, indications, side effects, and trends
THE PAPER
Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.
Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Cross JH, Dahlin MG, Donner EJ, Guzel O, Jehle RS, Klepper J, Kang HC, Lambrechts DA, Liu YMC, Nathan JK, Nordli DR, Pfeifer HH, Rho JM, Scheffer IE, Sharma S, Stafstrom CE, Thiele EA, Turner Z, Vaccarezza MM, van der Louw EJTM, Veggiotti P, Wheless JW, Wirrell EC, Charlie Foundation, Matthew's Friends, Practice Committee of the Child Neurology Society. Epilepsia Open, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.